Mind Medicine (MindMed) (MNMD) News Today $6.78 -0.14 (-2.02%) Closing price 04:00 PM EasternExtended Trading$6.89 +0.11 (+1.61%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Mind Medicine appoints Matt Wiley as CCOMarch 18, 2025 | markets.businessinsider.comMindMed Appoints Matt Wiley as Chief Commercial OfficerMarch 17, 2025 | businesswire.comWealthfront Advisers LLC Buys New Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Wealthfront Advisers LLC bought a new stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 103,086 shares of the company's stock, valued at approximately $717,000March 16, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for MNMD FY2029 Earnings?Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - HC Wainwright upped their FY2029 earnings estimates for Mind Medicine (MindMed) in a research note issued to investors on Friday, March 7th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn $2.86 per share forMarch 10, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Price Target Cut to $16.00 by Analysts at Robert W. BairdRobert W. Baird dropped their target price on shares of Mind Medicine (MindMed) from $27.00 to $16.00 and set an "outperform" rating for the company in a research report on Friday.March 8, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $55.00 price objective on shares of Mind Medicine (MindMed) in a research note on Friday.March 8, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPSMind Medicine (MindMed) (NASDAQ:MNMD - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.08). During the same period in the prior year, the business posted ($0.59) earnings per share.March 7, 2025 | marketbeat.comMind Medicine (MindMed) Inc. 2024 Q4 - Results - Earnings Call PresentationMarch 6, 2025 | seekingalpha.comMindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business UpdatesMarch 6, 2025 | finance.yahoo.comPsychedelic: MindMed reports Q4 earnings resultsMarch 6, 2025 | markets.businessinsider.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives $26.33 Consensus Price Target from BrokeragesShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received a consensus recommendation of "Buy" from the thirteen brokerages that are currently covering the firm, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy rating and three havMarch 4, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025March 1, 2025 | msn.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from AnalystsShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received a consensus rating of "Buy" from the thirteen research firms that are currently covering the stock, MarketBeat Ratings reports. Ten analysts have rated the stock with a buy recommendation and three have assigned aMarch 1, 2025 | marketbeat.comMind Medicine (MindMed) (MNMD) Expected to Announce Quarterly Earnings on ThursdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=668364)February 27, 2025 | marketbeat.comMind Medicine (MindMed) (MNMD) Expected to Announce Earnings on WednesdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Wednesday, February 26. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=668364)February 24, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - Here's WhyMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - Should You Sell?February 21, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3% - Time to Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3% - Should You Sell?February 19, 2025 | marketbeat.comMind Medicine (MindMed) (MNMD) Projected to Post Quarterly Earnings on WednesdayMind Medicine (MindMed) (NASDAQ:MNMD) will be releasing earnings before the market opens on Wednesday, February 26.February 19, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Time to Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedFebruary 16, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Time to Buy?February 15, 2025 | marketbeat.comWhy Mind Medicine Stock Is Skyrocketing TodayFebruary 14, 2025 | fool.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 9% - Should You Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 9% - Time to Sell?February 7, 2025 | marketbeat.comAnalysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) PT at $26.33Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have been given an average rating of "Buy" by the thirteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a buy recommendation and three havFebruary 7, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?February 6, 2025 | marketbeat.comMind Medicine (MNMD) Gets a Buy from H.C. WainwrightFebruary 5, 2025 | markets.businessinsider.comMind Medicine trading higher after zerohedge compares to OkloFebruary 5, 2025 | markets.businessinsider.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading 5.5% Higher - What's Next?February 5, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Sees Strong Trading Volume - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Sees Large Volume Increase - Should You Buy?February 4, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Average Rating of "Buy" by BrokeragesShares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) have received a consensus recommendation of "Buy" from the thirteen research firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a buy rating and three haveFebruary 4, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - Time to Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Up 5.5% - Time to Buy?February 3, 2025 | marketbeat.comAnalysts Issue Forecasts for MNMD FY2029 EarningsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Research analysts at HC Wainwright issued their FY2029 earnings estimates for shares of Mind Medicine (MindMed) in a research note issued to investors on Friday, January 31st. HC Wainwright analyst P. Trucchio forecasts that the company wFebruary 3, 2025 | marketbeat.comH.C. Wainwright Sticks to Their Buy Rating for Mind Medicine (MNMD)January 31, 2025 | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Mind Medicine (MindMed) (NASDAQ:MNMD)HC Wainwright reissued a "buy" rating and issued a $55.00 price target on shares of Mind Medicine (MindMed) in a report on Friday.January 31, 2025 | marketbeat.comLeerink Partnrs Has Bearish Outlook for MNMD Q4 EarningsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities research analysts at Leerink Partnrs reduced their Q4 2024 earnings estimates for shares of Mind Medicine (MindMed) in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now forecasts that theJanuary 31, 2025 | marketbeat.comMind Medicine doses first patient in Panorama studyJanuary 30, 2025 | markets.businessinsider.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's WhyMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Here's What HappenedJanuary 30, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for MNMD Q1 Earnings?Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Mind Medicine (MindMed) in a research note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman forecasts that the compJanuary 30, 2025 | marketbeat.comMindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety DisorderJanuary 30, 2025 | businesswire.comMindMed's LSD Anxiety Drug: Revisiting, Rethinking, But Maintaining My 'Hold' CallJanuary 29, 2025 | seekingalpha.comMind Medicine (MindMed) (NASDAQ:MNMD) Now Covered by Evercore ISIEvercore ISI assumed coverage on shares of Mind Medicine (MindMed) in a report on Tuesday. They issued an "outperform" rating and a $23.00 target price on the stock.January 29, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - Still a Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Up - What's Next?January 28, 2025 | marketbeat.comEvercore ISI sets $23 target on MindMed stock, sees potentialJanuary 28, 2025 | msn.comMind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated by Analysts at Evercore ISIEvercore ISI started coverage on Mind Medicine (MindMed) in a report on Tuesday. They issued an "outperform" rating and a $23.00 price objective for the company.January 28, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4% - What's Next?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 6.4% - Here's What HappenedJanuary 17, 2025 | marketbeat.comBarclays PLC Buys 91,271 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Barclays PLC lifted its stake in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 203.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 136,098 shares of the company's stock after buying an additionalJanuary 16, 2025 | marketbeat.comMind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of "Buy" from AnalystsMind Medicine (MindMed) Inc. (NASDAQ:MNMD - Get Free Report) has earned an average recommendation of "Buy" from the twelve ratings firms that are presently covering the company, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy rating and three have given a strong bJanuary 10, 2025 | marketbeat.comWhy Mind Medicine Stock Is Soaring TodayJanuary 7, 2025 | fool.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading 7.8% Higher - Should You Buy?Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Up 7.8% - Time to Buy?January 6, 2025 | marketbeat.comMind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 3.7% - Should You Sell?Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 3.7% - Time to Sell?January 3, 2025 | marketbeat.comGeode Capital Management LLC Has $9.55 Million Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)Geode Capital Management LLC grew its stake in shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD - Free Report) by 10.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,677,702 shares of the company's stock after purcJanuary 2, 2025 | marketbeat.com Remove Ads Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address MNMD Media Mentions By Week MNMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNMD News Sentiment▼0.000.68▲Average Medical News Sentiment MNMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNMD Articles This Week▼13▲MNMD Articles Average Week Remove Ads Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARQT News TARS News HRMY News TVTX News JANX News IRON News AGIO News APGE News MESO News VERA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNMD) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
